Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Shilpa Medicare hits record high on USFDA nod for cancer drug

Shilpa Medicare rallied 3.31% to Rs 756.85 after the company announced that it has received the U.S. Food and Drug Administration (USFDA) approval for its second new drug application (NDA), Bortezomib injection.

By: business-standard.com

Aug 27 2024
0
0 Views

Shilpa Medicare hits record high on USFDA nod for cancer drug

Shilpa Medicare hits record high on USFDA nod for cancer drug

Related

Adani Energy Solutions Ltd slips for fifth straight session

Railtel Corp bags order worth Rs 71-cr from Eastern Railway

Here is why SBI Life, HDFC Life, LIC shares rallied up to 4% on BSE today

SBI Card, Usha Martin: These 3 stocks crossed 200-DMA; what to expect next?

Volumes jump at Tata Investment Corporation Ltd counter

Ramesh Damani Portfolio: This jewellery stock has zoomed 90% in 15 days

Indices trade with small gains; FMCG shares slide

Shilpa Medicare hits record high on USFDA nod for cancer drug

DEE Development Engineers shares soar on order win from L&T's unit

Sakuma Exports Ltd leads losers in 'B' group

Minda Corporation Ltd leads losers in 'A' group

USFDA approval sends this multibagger pharma stock to 52-week high

Adani Energy Solutions Ltd slips for fifth straight session